Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis
- PMID: 19793459
- PMCID: PMC2703157
Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis
Abstract
Since the anthrax attacks of 2001, the emphasis on developing animal models of aerosolized select agent pathogens has increased. Many scientists believe that nonhuman primate models are the most appropriate to evaluate pulmonary response to, vaccines for, and treatments for select agents such as Yersinia pestis (Y. pestis), the causative agent of plague. A recent symposium concluded that the cynomolgus macaque (Macaca fascicularis) plague model should be characterized more fully. To date, a well-characterized cynomolgus macaque model of pneumonic plague using reproducible bioaerosols of viable Y. pestis has not been published. In the current study, methods for creating reproducible bioaerosols of viable Y. pestis strain CO92 (YpCO92) and pneumonic plague models were evaluated in 22 Indonesian-origin cynomolgus macaques. Five macaques exposed to doses lower than 250 CFU remained free of any indication of plague infection. Fifteen macaques developed fever, lethargy, and anorexia indicative of clinical plague. The 2 remaining macaques died without overt clinical signs but were plague-positive on culture and demonstrated pathology consistent with plague. The lethal dose of plague in humans is reputedly less than 100 organisms; in this study, 66 CFU was the dose at which half of the macaques developed fever and clinical signs (ED(50)), The Indonesian cynomolgus macaque reproduces many aspects of human pneumonic plague and likely will provide an excellent model for studies that require a macaque model.
Figures




Similar articles
-
Milestones in progression of primary pneumonic plague in cynomolgus macaques.Infect Immun. 2010 Jul;78(7):2946-55. doi: 10.1128/IAI.01296-09. Epub 2010 Apr 12. Infect Immun. 2010. PMID: 20385751 Free PMC article.
-
Cynomolgus macaque model for pneumonic plague.Microb Pathog. 2011 Jan;50(1):12-22. doi: 10.1016/j.micpath.2010.10.002. Epub 2010 Oct 30. Microb Pathog. 2011. PMID: 21040776
-
Efficacy of primate humoral passive transfer in a murine model of pneumonic plague is mouse strain-dependent.J Immunol Res. 2014;2014:807564. doi: 10.1155/2014/807564. Epub 2014 Jul 6. J Immunol Res. 2014. PMID: 25097863 Free PMC article.
-
Yersinia pestis and the plague.Am J Clin Pathol. 2003 Jun;119 Suppl:S78-85. doi: 10.1309/DQM9-3R8Q-NQWB-FYU8. Am J Clin Pathol. 2003. PMID: 12951845 Review.
-
Pathology and Pathogenesis of Yersinia pestis.Adv Exp Med Biol. 2016;918:193-222. doi: 10.1007/978-94-024-0890-4_7. Adv Exp Med Biol. 2016. PMID: 27722864 Review.
Cited by
-
Levofloxacin cures experimental pneumonic plague in African green monkeys.PLoS Negl Trop Dis. 2011 Feb 8;5(2):e959. doi: 10.1371/journal.pntd.0000959. PLoS Negl Trop Dis. 2011. PMID: 21347450 Free PMC article.
-
A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Clin Vaccine Immunol. 2016 Jul 5;23(7):586-600. doi: 10.1128/CVI.00150-16. Print 2016 Jul. Clin Vaccine Immunol. 2016. PMID: 27170642 Free PMC article.
-
Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.J Med Primatol. 2011 Feb;40(1):6-17. doi: 10.1111/j.1600-0684.2010.00443.x. Epub 2010 Aug 16. J Med Primatol. 2011. PMID: 20722770 Free PMC article.
-
Milestones in progression of primary pneumonic plague in cynomolgus macaques.Infect Immun. 2010 Jul;78(7):2946-55. doi: 10.1128/IAI.01296-09. Epub 2010 Apr 12. Infect Immun. 2010. PMID: 20385751 Free PMC article.
-
Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus.J Virol. 2011 Dec;85(24):12995-3009. doi: 10.1128/JVI.05840-11. Epub 2011 Oct 12. J Virol. 2011. PMID: 21994460 Free PMC article.
References
-
- Adamovicz JJ, Worsham PL. 2006. Plague. In: Swearengen J. Biodefense research metholodogy and animal models. Boca Raton: Taylor & Francis; p 107–135
-
- Clark AR, Chambers CB, Muir D, Newhouse MT, Paboojian S, Schuler C. 2007. The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 μm) bolus aerosols. J Aerosol Med 20:75–82 - PubMed
-
- Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Frielander AM. 1996. Pathology of experimental pneumonic plague produced by fraction-1-positive and fraction-1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med 120:156–162 - PubMed
-
- Dixon WJ. 1965. The up–down method for small samples. J Am Stat Assoc 60:967–978
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical